贾威阳河可以通过调节NR1D1/2并抑制Th17细胞来缓解肺癌

相关实验视频

Updated: Jun 1, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

493

Jie Cui1, Zhuannan Hu1, Yuwei Jiang1

  • 1Institute of Respiratory Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.

Journal of ethnopharmacology
|January 18, 2025
PubMed
概括

贾威阳河脱 (JWYHD) 通过减少颗粒瘤和抑制Th17细胞,有效治疗肺癌. 这种传统中医药通过上调NR1D1/2的表达来显示治疗潜力,为肉病治疗提供了一个新的标.

关键词:
贾威阳 (Jiawei yanghe decoction,简称JWYHD) 是一种制剂.这就是NR1D1的特点.在NR1D2中,它是NR1D2.肺部型硬化症 肺部型硬化症Th17 这是一个很好的方法.

更多相关视频

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

808

相关概念视频

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K